| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.22B | 4.40B | 3.85B | 2.44B | 1.97B | 1.49B |
| Gross Profit | 1.63B | 1.64B | 1.33B | 836.88M | 682.26M | 527.74M |
| EBITDA | 1.00B | 928.12M | 723.50M | 301.35M | 175.09M | 115.44M |
| Net Income | 182.50M | 110.72M | -252.04M | -85.24M | -27.09M | -7.32M |
Balance Sheet | ||||||
| Total Assets | 7.28B | 7.08B | 7.69B | 6.59B | 2.82B | 2.65B |
| Cash, Cash Equivalents and Short-Term Investments | 325.40M | 335.97M | 334.26M | 208.69M | 138.77M | 343.45M |
| Total Debt | 3.70B | 3.77B | 3.92B | 3.51B | 1.49B | 1.35B |
| Total Liabilities | 5.47B | 5.46B | 5.91B | 5.04B | 2.28B | 2.00B |
| Stockholders Equity | 1.66B | 1.48B | 1.47B | 1.06B | 495.82M | 600.93M |
Cash Flow | ||||||
| Free Cash Flow | 499.74M | 577.64M | 417.25M | 10.67M | -106.03M | 27.38M |
| Operating Cash Flow | 633.32M | 668.50M | 582.41M | 162.64M | 183.34M | 156.30M |
| Investing Cash Flow | -183.01M | -236.82M | -173.15M | -3.21B | -291.99M | -125.93M |
| Financing Cash Flow | -426.35M | -418.12M | -370.00M | 3.13B | -102.13M | 272.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $747.11M | 99.56 | 6.65% | ― | 18.37% | ― | |
60 Neutral | $483.80M | 0.93 | ― | ― | 0.74% | ― | |
58 Neutral | $380.43M | 7.40 | 11.61% | ― | 2.14% | ― | |
54 Neutral | $657.50M | -12.23 | -44.33% | ― | 34.99% | -68.73% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | $286.32M | -18.10 | -3.76% | ― | -22.14% | -787.87% | |
46 Neutral | $107.70M | -5.80 | -21.85% | ― | -16.54% | -119.56% |
On November 20, 2025, Auna S.A. announced its financial results for the third quarter of 2025, highlighting a mixed performance across its operations in Peru, Colombia, and Mexico. While the company saw growth in Peru and Colombia, with increased revenues and profitability in local currencies, Mexico faced challenges with declining revenues and profitability due to legacy issues and system migrations. Despite these challenges, Auna maintained a stable leverage ratio and completed a significant debt refinancing, positioning itself for future growth and operational improvements.
The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.
On November 20, 2025, Auna S.A. announced a strategic collaboration with Sojitz Corporation of America to explore joint business opportunities in the healthcare sector across Latin America, initially focusing on Mexico. This partnership aims to leverage Auna’s healthcare expertise and Sojitz’s investment capabilities to develop scalable and accessible healthcare infrastructure in the region. Previously, on September 24, 2025, Auna declared its intention to invest approximately $500 million over the next three to five years to expand its healthcare platform in Mexico, marking a significant step in its strategy to enhance healthcare access in Latin America.
The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.
On November 7, 2025, Auna S.A. announced the completion of a US$765 million debt refinancing, which strengthens its capital structure by extending debt maturities, reducing interest expenses, and enhancing liquidity. This refinancing involved issuing new Senior Secured 2032 Notes and a Term Loan, with significant participation from the International Finance Corporation. The transaction is expected to improve Auna’s financial position, aiding its strategic growth initiatives and expanding healthcare access in Latin America.
The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.
On November 4, 2025, Auna S.A. announced the successful pricing of $365 million in 8.750% Senior Secured Notes due 2032. The issuance, co-led with Oncosalud S.A.C., aims to fund a tender offer for its existing 10.000% Senior Secured Notes due 2029 and to prepay certain debts. This strategic financial move is expected to optimize Auna’s capital structure and enhance its financial flexibility, potentially strengthening its position in the Latin American healthcare market.
The most recent analyst rating on (AUNA) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Auna S.A. Class A stock, see the AUNA Stock Forecast page.